Shenzhen Salubris Pharmaceuticals Co.
Venture Capital
Chinese pharma company (SZSE: 002294) making strategic investments in cardiovascular and biotech.
Shenzhen, China · 1+ investments
Late Stage
Growth
Biotech
Cardiovascular
Medical Devices
- Headquarters
- Shenzhen, China
- Founded
- 1998
- Website
- salubris.com
- Total Investment
- 1
- Last Investment
- Jun 2018
- Geographic Focus
- China, United States
Investment Thesis
Strategic corporate venture investments in medical technology and biotech aligned with cardiovascular, oncology, and biologics pipeline.
Shenzhen Salubris Pharmaceuticals Co. is a Venture Capital firm based in Shenzhen, China. It has made 1 investment in Biotech and Cardiovascular.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.